Skip to content
Home/Companies/Healthcare / Biotech/BioClec

BioClec

Healthcare / Biotech·Italy·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns BioClec?

BioClec is currently owned by Sofinnova Partners through Sofinnova Biovelocita I (2022 vintage), since 2023.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Biovelocita I · 2022 · Life Sciences VC

Key facts

HQItaly
SectorHealthcare / Biotech

More from Sofinnova Biovelocita I

Other portfolio companies in the same fund.

Forth Therapeutics
Forth Therapeutics
Active
BiotechItaly· 2023

More Sofinnova Partners portfolio companies

From the same investor, across funds.

GenSight Biologics
GenSight Biologics
Active
BiotechFrance
Ingenix
Active
AI/MLPoland· 2026
Actithera
Actithera
Active
BiotechFrance· 2025
Bionyra Pharma
Active
BiotechFrance· 2025
Excelsior Sciences
Active
HealthTechUS· 2025
Latent Labs
Latent Labs
Active
HealthTechUK· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track BioClec

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy BioClec?

0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on BioClec.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue